Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-03-27 @ 11:35 PM
Study NCT ID:
NCT06716658
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2024-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Sponsor:
Organization: